This presentation will begin on Wednesday, October 13th, 2021, at 02:00 PM Eastern Daylight Time.
The focus of this presentation will be to explore the pathophysiology of COVID-19-associated coagulopathy and how the thrombinflammatory response (e.g., cytokine storm) contributes to severe coagulation abnormalities in COVID-19 patients. In addition, this presentation will also explore the potential mechanisms and laboratory parameters/markers that are helpful in guiding the management/monitoring of COVID-19 patients.
Dr. John Mitsios, PhD, Senior Clinical Hemostasis Consultant at Siemens Healthineers will help you:
- Understand SARS -CoV-2 virus and COVID-19 disease
- Review basics of hemostasis – primary, secondary, and tertiary and the role of endothelial cells
- Describe pathophysiology of COVID-19 Coagulopathy
- Explain the role of laboratory testing and expected results in COVID-19 patients
Dr. Mitsios graduated from the University of Ioannina, Greece with a PhD in Chemistry. Upon completion of his doctoral thesis, he then went on to complete a post-doctoral fellowship at the University of California, San Diego under the mentorship of Dr. Sanford J. Shattil. Dr. Mitsios then transitioned to the world of Clinical Chemistry and completed a fellowship at Washington University in St. Louis, MO. His primary research interest throughout his education and training has been in coagulation, with an emphasis on platelet function and biology. Recently Dr. Mitsios joined Siemens-Healthineers as a clinical consultant as part of the Scientific and Clinical Affairs team. In addition, Dr. Mitsios has co-authored 20 peer-reviewed articles and 3 book chapters.
